In a surprising finding, heart attack patients treated with a substantially lower dosage of beta-blockers than used in earlier clinical trials showing their effectiveness survived at the same rate, or ...

"We set out on a mission to show if you treat patients with the doses that were used in the clinical trials, they will do better," says Jeffrey Goldberger. "We expected to see patients treated with ...

Current guideline recommendations for the use of beta-blockers after myocardial infarction without reduced ejection fraction are based on trials conducted before routine reperfusion, invasive care, ...

CHICAGO –For nearly 40 years a class of drugs known as beta blockers have been proven to increase patients' survival prospects following a heart attack by decreasing the cardiac workload and oxygen ...

If there is a benefit to continuing beta-blockers beyond 1 year after acute MI, it might come with a lower dose. And for patients with LV dysfunction after STEMI, mineralocorticoid receptor ...

If you have an abnormal heart rhythm or another heart condition like high blood pressure, a beta-blocker may be a key part of your treatment plan. Beta-blockers, such as atenolol, metoprolol, and ...

Patients on one-fourth the dose tested in large clinical trials have 20 to 25 percent increase in survival Findings are opposite of what was expected Beta-blocker dosing likely needs to be ...